Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases.
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
A Navy veteran recently said that an experimental immunotherapy treatment and his faith both played key roles in helping him defeat cancer.
News Medical on MSN2h
Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancerPatients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
News Medical on MSN7d
Gut microbes influence how well cancer patients respond to immunotherapyResearchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...
The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.
Racial and ethnic disparities were identified in immunotherapy receipt for Black patients with metastatic triple-negative ...
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback